Brandes U.S. Equity Fd Srs A (BIP141)
33.01
-0.20
(-0.60%)
CAD |
Dec 31 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.07% | 178.06M | 1.98% | 4.92% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -3.054M | 10.44% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The fundamental investment objective of the U.S. Equity Fund is to achieve long-term capital appreciation by investing primarily in the equity securities of U.S. issuers with equity market capitalizations that exceed $1 billion at the time of purchase. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | U.S. Equity |
| Global Macro | Equity North America |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Bridgehouse |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
36
-626.58M
Peer Group Low
667.97M
Peer Group High
1 Year
% Rank:
62
-3.054M
-1.829B
Peer Group Low
4.224B
Peer Group High
3 Months
% Rank:
49
-671.21M
Peer Group Low
828.71M
Peer Group High
3 Years
% Rank:
70
-5.201B
Peer Group Low
12.33B
Peer Group High
6 Months
% Rank:
52
-796.71M
Peer Group Low
1.754B
Peer Group High
5 Years
% Rank:
74
-4.966B
Peer Group Low
15.09B
Peer Group High
YTD
% Rank:
--
-709.70M
Peer Group Low
965.68M
Peer Group High
10 Years
% Rank:
76
-6.438B
Peer Group Low
16.96B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 02, 2026.
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 2.60% |
| Stock | 97.40% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Merck & Co., Inc. | 3.19% | 106.47 | 1.15% |
| Citigroup, Inc. | 2.60% | 118.44 | 1.50% |
|
CAD Cash
|
2.60% | -- | -- |
| Bank of America Corp. | 2.53% | 55.88 | 1.60% |
| Textron, Inc. | 2.46% | 87.17 | 0.00% |
| HCA Healthcare, Inc. | 2.39% | 469.79 | 0.63% |
| Wells Fargo & Co. | 2.32% | 94.96 | 1.88% |
| Pfizer Inc. | 2.28% | 25.17 | 1.08% |
| Becton, Dickinson & Co. | 2.26% | 195.04 | 0.50% |
| Alphabet, Inc. | 2.19% | 315.24 | 0.46% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP |
|
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 100.00 None |
Basic Info
| Investment Strategy | |
| The fundamental investment objective of the U.S. Equity Fund is to achieve long-term capital appreciation by investing primarily in the equity securities of U.S. issuers with equity market capitalizations that exceed $1 billion at the time of purchase. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | U.S. Equity |
| Global Macro | Equity North America |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Bridgehouse |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (12-31-25) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 63 |
| Stock | |
| Weighted Average PE Ratio | 20.92 |
| Weighted Average Price to Sales Ratio | 2.388 |
| Weighted Average Price to Book Ratio | 2.774 |
| Weighted Median ROE | 362.5% |
| Weighted Median ROA | 5.59% |
| ROI (TTM) | 10.14% |
| Return on Investment (TTM) | 10.14% |
| Earning Yield | 0.0600 |
| LT Debt / Shareholders Equity | 2.458 |
| Number of Equity Holdings | 62 |
As of November 30, 2025
Growth Metrics
| EPS Growth (1Y) | 19.95% |
| EPS Growth (3Y) | 5.37% |
| EPS Growth (5Y) | 10.10% |
| Sales Growth (1Y) | 4.80% |
| Sales Growth (3Y) | 5.89% |
| Sales Growth (5Y) | 6.19% |
| Sales per Share Growth (1Y) | 7.13% |
| Sales per Share Growth (3Y) | 8.45% |
| Operating Cash Flow - Growth Rate (3Y) | 1.25% |
As of November 30, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:BIP141.TO", "name") |
| Broad Asset Class: =YCI("M:BIP141.TO", "broad_asset_class") |
| Broad Category: =YCI("M:BIP141.TO", "broad_category_group") |
| Prospectus Objective: =YCI("M:BIP141.TO", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |